Imatinib Terminated Phase 2 / 3 Trials for Malignant Peripheral Nerve Sheath Tumour (MPNST) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs